Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection
Background. Acute perivascular rejection (AR) is common in lung recipients and increases the risk for chronic lung allograft dysfunction (CLAD). Hyaluronan (HA), an extracellular matrix constituent, accumulates in experimental AR and can act as an innate immune agonist, breaking tolerance and potent...
Main Authors: | Haley P. Hostetler, MD, Megan L. Neely, PhD, Francine L. Kelly, PhD, John A. Belperio, MD, Marie Budev, MD, John M. Reynolds, MD, Pali D. Shah, MD, Lianne G. Singer, MD, Laurie D. Snyder, MD, Scott M. Palmer, MD, Jamie L. Todd, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2021-04-01
|
Series: | Transplantation Direct |
Online Access: | http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001138 |
Similar Items
-
Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?
by: Tetsuya Tajima, MD, et al.
Published: (2019-10-01) -
Response to Treatment for Chronic-active T Cell–mediated Rejection in Kidney Transplantation: A Report of 3 Cases
by: Hiroshi Noguchi, MD, PhD, et al.
Published: (2020-12-01) -
The MEK Inhibitor Trametinib Suppresses Major Histocompatibility Antigen-mismatched Rejection Following Pancreatic Islet Transplantation
by: Seiichiro Tada, MD, et al.
Published: (2020-09-01) -
Cellular Mechanisms of Rejection of Optic and Sciatic Nerve Transplants: An Observational Study
by: Merve Yonar, MD, et al.
Published: (2020-08-01) -
Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation?
by: Marcio F. Chedid, MD, PhD, et al.
Published: (2019-10-01)